Antimicrobial drug resistance (AMR) is an increasing global health problem. National and international bodies perceive new antimicrobial drug development as a priority. Co-sponsored by the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) and the American Society for Microbiology (ASM), 2022 ESCMID/ASM Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance will take place in Dublin, Ireland, 4-7 October 2022. This multidisciplinary meeting will address the challenges, opportunities, and current requirements for antimicrobial drug development to address antimicrobial resistance. For more information and registration details, please visit the conference website.

Liverpool

Birmingham / Hybrid

Birmingham

Perth, Australia